Member access

4-Traders Homepage  >  Shares  >  Nyse  >  St. Jude Medical, Inc.    STJ   US7908491035

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

St. Jude Medical, Inc. : StockCall Scrutinizes STJ, HOLX, NAVB, EW, and RMD

05/17/2013 | 08:35am US/Eastern

StockCall.com Provides Stock Research on St. Jude Medical Inc., Hologic Inc., Navidea Biopharmaceuticals Inc., Edwards Lifesciences Corp., and ResMed Inc.

New York City, New York -- (May 17, 2013)

The Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades, has generally been welcomed by the healthcare industry. The industry believes that the increase in the number of insured individuals due to the ACA will ultimately benefit it. However, medical appliances & equipment makers have been the most vocal critics of the reform. This is because medical appliances & equipment are required to pay a 2.3% tax on gross U.S. sales of medical devices. The industry believes that this will result in higher costs and hurt innovation. On Thursday, shares of medical appliances & equipment companies ended mostly lower, tracking losses in the broad market. Among the major movers in the sector were St. Jude Medical Inc. (NYSE: STJ), Hologic Inc. (NASDAQ: HOLX), Navidea Biopharmaceuticals Inc. (AMEX: NAVB), Edwards Lifesciences Corp. (NYSE: EW), and ResMed Inc. (NYSE: RMD). StockCall reviewed the medical appliances & equipment industry and chose STJ, HOLX, NAVB, EW, and RMD for its technical coverage. These free reports can be seen for free at

www.stockcall.com/signup

Shares of St. Jude Medical Inc. edged higher on Thursday, touching a 52-week high of $47.14. The stock closed 0.54% higher at $46.82 on above average volume of 3.43 million. St. Jude Medical?s shares have gained more than 3.50% in the last three trading sessions. The stock has seen a series of highs over the past two weeks which is a bullish signal. Despite the challenges facing the industry, shares of STJ have gained more than 30.30% so far in 2013. Download the free research on STJ by signing up now at

www.StockCall.com/STJ051713.pdf

Shares of Hologic Inc. fell in trading yesterday, extending its losses from previous trading sessions. The stock ended the day 1.04% lower at $20.87 on volume of 2.12 million, taking its losses in the last three sessions to more than 2.10%. Year-to-date, shares of HOLX have gained 4.30% as compared to a growth of more than 15.70% for the S&P 500. The stock is currently trading 12.90% below its 52-week high. Shares are currently trading below their 50-day and 200-day moving averages which is a bearish signal. Register for today?s free analysis on HOLX at

www.StockCall.com/HOLX051713.pdf

Navidea Biopharmaceuticals Inc.?s shares fell sharply on Thursday. The stock finished the day 2.49% lower at $2.35 on volume of 607,040. Navidea?s shares are currently trading close to their 52-week low of $2.14. The stock has fallen nearly 17% so far this year even as the broad market has rallied. The company?s shares are currently trading well below their 50-day and 200-day moving averages. Free report on NAVB can be accessed by registering at

www.StockCall.com/NAVB051713.pdf

Shares of Edwards Lifesciences Corp. struggled in trading yesterday. The stock traded between $67.75 and $70.85 before finishing the day 3.56% lower at $68.81 on above average volume of 2 million. Despite the sharp decline on Thursday, Edwards Lifesciences? shares are up nearly 1.90% in the last three trading sessions. The stock had seen a series of highs this week before seeing a pullback yesterday. Shares of the company have fallen nearly 24% so far in 2013.Register withStockCall and download the research on EW for free at

www.StockCall.com/EW051713.pdf

Shares of ResMed Inc. edged lower on Thursday. The stock closed 1.46% lower at $49.80 on volume of 1.05 million which is in-line with the daily average. Despite the pullback, ResMed?s shares are currently trading close to their 52-week high of $51.40. The stock has outperformed the broad market this year, gaining more than 20.20%. Shares of the company are also trading well above their 50-day and 200-day moving averages. Read the full free research on RMD by signing up to StockCall at

www.StockCall.com/RMD051713.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)


© Accesswire 2013
React to this article
Latest news on ST. JUDE MEDICAL, INC.
6h ago ST JUDE MEDICAL : Researchers Submit Patent Application, "Guiding Medical Device..
6h ago ST JUDE MEDICAL : Patent Application Titled "Steering Actuator for Deflectable C..
1d ago ST JUDE MEDICAL : Investigators from St. Jude Medical, Inc. Zero in on Cardiolog..
2d ago ST JUDE MEDICAL : CardiAQ Valve Technologies Names Jack Lips and Steven Marmon a..
3d ago ST JUDE MEDICAL : Data from St. Jude Medical Finds CardioMEMS HF System Reduced ..
5d ago ST JUDE MEDICAL : CardioMEMS HF System Reduces 30-Day Hospital Readmission Rates
7d ago Ambu Announces Hiring Of A Global Chief Innovation Officer
11/20 ST JUDE MEDICAL : Patent Issued for Tissue Anchor Apparatus
11/19 ST JUDE MEDICAL : Patent Issued for Collapsible/Expandable Prosthetic Heart Valv..
11/18 ST JUDE MEDICAL : Data Shows the CardioMEMS HF System Significantly Reduced 30-D..
Advertisement
Chart
Duration : Period :
St. Jude Medical, Inc. Technical Analysis Chart | STJ | US7908491035 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF